Antiplatelet therapies in patients with an indication for anticoagulation.

about

Pharmacosimulation of interruptions and its solution in intravenous administration of cangrelor.Effects of Tacrolimus or Sirolimus on the adhesion of vascular wall cells: Controlled in-vitro comparison study.

P2860

Q47646996-F4806221-C316-4304-9882-3448ED86DC19 Q50225555-72F2B15A-447E-4C6B-A5E2-DCBCF9E8249B

P2860

Antiplatelet therapies in patients with an indication for anticoagulation.

Item

http://www.wikidata.org/entity/Q38995602

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Antiplatelet therapies in patients with an indication for anticoagulation.

@en

type

Item

label

Antiplatelet therapies in patients with an indication for anticoagulation.

@en

prefLabel

Antiplatelet therapies in patients with an indication for anticoagulation.

@en

P1476

Antiplatelet therapies in patients with an indication for anticoagulation.

@en

P2093

Helen Ullrich

http://www.w3.org/2001/XMLSchema#string

Tommaso Gori

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma.

Temporal relationship between subclinical atrial fibrillation and embolic events.

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.

P304

273-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CH-168104

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28128753

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Antiplatelet therapies in patients with an indication for anticoagulation.

about

P2860

P2860

Antiplatelet therapies in patients with an indication for anticoagulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921